Skip to main contentSkip to navigation
Sirius Investors
BG Medicine, Inc.

BG Medicine, Inc.

BGMD
OTCHealthcare

BG Medicine, Inc. (BGMD) Investment Research Dashboard

About BG Medicine, Inc. (BGMD) stock analysis

Get live BGMD stock price $0.00, comprehensive BG Medicine, Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time BGMD stock data and investment insights.

0.00
0.00%Today
Market Cap
1.14K
Volume
450
52W High
0.00
52W Low
0.00

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

BG Medicine, Inc. is dedicated to the development and commercialization of diagnostic products aimed at guiding patient care for individuals in the United States afflicted with heart failure and related conditions. Its product portfolio includes the ...

Company Information

CEO
Stephen Hall
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
5

Contact Information

Address
303 Wyman Street
Country
US

Investment Analysis & Business Insights

Healthcare
Medical - Instruments & Supplies

Investment Highlights

Strong presence in the Healthcare sector with established market position

Lower volatility stock (Beta: -44.60) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for BG Medicine, Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for BG Medicine, Inc.
  • Investors should consider how BG Medicine, Inc. fits within their overall portfolio allocation

Market Cap

1.14K

Beta

-44.60

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

75/100 ⭐⭐⭐⭐⭐

Overall
+0.5%
NYSE
+0.6%
NASDAQ
+0.5%
Sector1D1W1MP/EScore
Financial Services+1.8%+2.8%+3.9%19.3
98/100⭐⭐⭐⭐⭐
Healthcare+0.5%+1.2%+1.4%24.0
75/100⭐⭐⭐⭐⭐
Communication Services+1.4%-0.6%+3.0%22.2
74/100⭐⭐⭐⭐⭐
Basic Materials+0.6%+1.4%-0.1%25.2
66/100⭐⭐⭐⭐
Consumer Defensive+0.2%+2.2%+1.1%29.8
64/100⭐⭐⭐⭐
Real Estate+0.4%+0.9%-1.6%29.5
51/100⭐⭐⭐
Energy-1.8%-3.4%-3.8%19.2
39/100⭐⭐
Utilities-0.8%+0.2%-4.2%26.8
37/100⭐⭐
Consumer Cyclical+0.3%-1.7%-6.0%42.8
18/100
Industrials+0.2%-0.0%-10.3%30.0
15/100
Technology+0.3%-1.9%-7.4%40.6
13/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.